FDA's Social Media Guidance Skirts Questions Of Liability

Law360, New York (January 10, 2012, 7:57 PM EST) -- The U.S. Food and Drug Administration's long-awaited draft guidance on social media sets limits for how drugmakers can respond to questions about off-label uses, but provides no guidelines for responding to consumer queries on any other topics on Facebook and other sites, experts say.

"We have been hoping for some really broad-reaching guidance from the FDA. This obviously is not that document," Kaye Scholer LLP partner Lori Leskin said. “It is much more limited than what we were hoping for — are hoping for.”

The FDA...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.